{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:52:21Z","timestamp":1793839941835,"version":"4.6.1"},"reference-count":41,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Potts Memorial Foundation and NIH-NHLBI","award":["2R15HL143545-02"],"award-info":[{"award-number":["2R15HL143545-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mycobacterium avium is an opportunistic pathogen and a leading contributor to nontuberculous mycobacterial infections in immunocompromised individuals. However, treatment duration, antibiotic toxicity, and resistance present challenges in the management of mycobacterium infections, prompting the need for novel treatment. N-acetylcysteine (NAC) has demonstrated potent antimycobacterial activity, while antimicrobial peptides such as the cyclic [R4W4] have shown additive effects when combined with first-line antibiotics. This study aimed to investigate the mechanism and efficacy of NAC and [R4W4] combination therapy against M. avium. A membrane depolarization assay was used to evaluate the effects of NAC and [R4W4] on M. avium cell membrane integrity. Antimycobacterial activity was assessed by treating cultures with varying concentrations of NAC, [R4W4], a combination, or a sham treatment. The same regimens were applied to M. avium-infected THP-1-derived macrophages to assess intracellular efficacy. NAC and [R4W4] each disrupted the M. avium membrane potential, with enhanced effects in combination. The combination treatment significantly reduced M. avium survival in both the culture and infected macrophages compared with NAC alone and untreated controls. [R4W4] and NAC also demonstrated potent antibacterial activity, while the lowest MIC and the combination of [R4W4] and NAC displayed additive effects, indicating an improved bacterial inhibition compared to individual treatments. These findings demonstrate the additive activity of NAC and [R4W4] against M. avium in vitro and suggest that combining antioxidant compounds with antimicrobial peptides may represent a promising strategy for treating mycobacterial infections.<\/jats:p>","DOI":"10.3390\/ijms262110361","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:51:42Z","timestamp":1761526302000},"page":"10361","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Additive Effects of N-Acetylcysteine and [R4W4] Combination Treatment on Mycobacterium avium"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-3621","authenticated-orcid":false,"given":"Kayvan","family":"Sasaninia","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iffat Hasnin","family":"Era","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezam","family":"Newman","sequence":"additional","affiliation":[{"name":"College of Health Sciences, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Melendez","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajiha","family":"Akif","sequence":"additional","affiliation":[{"name":"College of Health Sciences, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eashan","family":"Sharma","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Nikjeh","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-6282","authenticated-orcid":false,"given":"Ira","family":"Glassman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"College of Science, California State Polytechnic State University, Pomona, CA 91768, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Crean College of Health Sciences, Chapman University, Orange, CA 92866, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ama","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Natural and Agricultural Sciences, University of California, Riverside, CA 92521, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lambros","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-7392","authenticated-orcid":false,"given":"Miou","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Dental Medicine, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-4548","authenticated-orcid":false,"given":"Rakesh","family":"Tiwari","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/microbiolspec.TNMI7-0045-2017","article-title":"Mycobacterium avium Complex Disease","volume":"5","author":"Daley","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.26444\/aaem\/136398","article-title":"The Mycobacterium avium complex\u2014An underestimated threat to humans and animals","volume":"29","author":"Kaczmarkowska","year":"2022","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tube.2018.12.004","article-title":"Mycobacterium avium: An overview","volume":"114","author":"Busatto","year":"2019","journal-title":"Tuberculosis"},{"key":"ref_5","unstructured":"Akram, S.M. (2025, October 23). Mycobacterium avium Complex, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK431110\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"809014","DOI":"10.1155\/2015\/809014","article-title":"General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J. Pathog."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Park, H.E., Lee, W., Choi, S., Jung, M., Shin, M.K., and Shin, S.J. (2022). Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.931876"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"(1997). Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria. Am. J. Respir. Crit. Care Med., 156, S1\u2013S25.","DOI":"10.1164\/ajrccm.156.2.atsstatement"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.micinf.2005.10.028","article-title":"Host genetic factors and mycobacterial infections: Lessons from single gene disorders affecting innate and adaptive immunity","volume":"8","author":"Doffinger","year":"2006","journal-title":"Microbes Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4046\/trd.2012.72.5.452","article-title":"Disseminated Mycobacterium intracellulare Infection in an Immunocompetent Host","volume":"72","author":"Kim","year":"2012","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12105-016-0738-1","article-title":"Mycobacterium avium Infection of Nasal Septum in a Diabetic Adult: A Case Report","volume":"10","author":"Xu","year":"2016","journal-title":"Head Neck Pathol."},{"key":"ref_12","first-page":"005621","article-title":"Chronic Lymphocytic Lymphoma Complicated by Mycobacterium Avium and Scedosporium Apiospermum","volume":"12","author":"Sivasubramanian","year":"2025","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_13","unstructured":"Welch, A. (2025, August 18). What Are Mycobacterium avium Complex Infections? Causes, Treatment, Prevention, and More. 6 November 2022. Available online: https:\/\/www.everydayhealth.com\/rare-diseases\/mycobacterium-avium-complex-infections\/."},{"key":"ref_14","first-page":"9","article-title":"Disseminated Mycobacterium avium on HIV\/AIDS: Historical and Current Literature Review","volume":"22","author":"Muniz","year":"2020","journal-title":"AIDS Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994-2007: A cohort study","volume":"24","author":"Buchacz","year":"2010","journal-title":"Aids"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.1984.03340340026019","article-title":"Mycobacterial Cervical Lymphadenopathy: Relation of Etiologic Agents to Age","volume":"251","author":"Lai","year":"1984","journal-title":"JAMA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/CVI.00208-10","article-title":"Mycobacterium avium complex cervical lymphadenitis in an immunocompetent adult","volume":"17","author":"Christensen","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.resinv.2022.05.006","article-title":"Treatment strategies with alternative treatment options for patients with Mycobacterium avium complex pulmonary disease","volume":"60","author":"Ito","year":"2022","journal-title":"Respir. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chest.2018.01.024","article-title":"Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic Review","volume":"153","author":"Diel","year":"2018","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2012.20.1.019","article-title":"Cyclic peptides as therapeutic agents and biochemical tools","volume":"20","author":"Joo","year":"2012","journal-title":"Biomol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/mp5003027","article-title":"Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens","volume":"11","author":"Oh","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sajid, M.I., Lohan, S., Kato, S., and Tiwari, R.K. (2022). Combination of Amphiphilic Cyclic Peptide [R(4)W(4)] and Levofloxacin against Multidrug-Resistant Bacteria. Antibiotics, 11.","DOI":"10.3390\/antibiotics11030416"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hernandez, J., Ashley, D., Cao, R., Abrahem, R., Nguyen, T., To, K., Yegiazaryan, A., Akinwale David, A., Kumar Tiwari, R., and Venketaraman, V. (2020). Cyclic Peptide [R(4)W(4)] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01677"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kelley, M., Sasaninia, K., Abnousian, A., Badaoui, A., Owens, J., Beever, A., Kachour, N., Tiwari, R.K., and Venketaraman, V. (2023). Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection. Pathogens, 12.","DOI":"10.3390\/pathogens12081057"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","article-title":"Molecular mechanisms of N-acetylcysteine actions","volume":"60","author":"Zafarullah","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine--a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Teskey, G., Cao, R., Islamoglu, H., Medina, A., Prasad, C., Prasad, R., Sathananthan, A., Fraix, M., Subbian, S., and Zhong, L. (2018). The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02069"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer, A.B., and Wenzel, M. (2020). A How-To Guide for Mode of Action Analysis of Antimicrobial Peptides. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.540898"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/18755305MTAwENDE80","article-title":"Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications","volume":"27","author":"Boparai","year":"2020","journal-title":"Protein Pept. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Amaral, E.P., Concei\u00e7\u00e3o, E.L., Costa, D.L., Rocha, M.S., Marinho, J.M., Cordeiro-Santos, M., D\u2019Imp\u00e9rio-Lima, M.R., Barbosa, T., Sher, A., and Andrade, B.B. (2016). N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions. BMC Microbiol., 16.","DOI":"10.1186\/s12866-016-0872-7"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"a021113","DOI":"10.1101\/cshperspect.a021113","article-title":"The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan","volume":"5","author":"Alderwick","year":"2015","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1042\/BCJ20200194","article-title":"The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host\u2019s immune system","volume":"477","author":"Batt","year":"2020","journal-title":"Biochem. J."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Moon, S.H., and Huang, E. (2019). Novel linear lipopeptide paenipeptin C\u2019 binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane. BMC Microbiol., 19.","DOI":"10.1186\/s12866-018-1381-7"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/acs.jpcb.2c04615","article-title":"Design of Peptides for Membrane Insertion: The Critical Role of Charge Separation","volume":"126","author":"Povilaitis","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jconrel.2020.10.049","article-title":"Macropinocytosis as a cell entry route for peptide-functionalized and bystander nanoparticles","volume":"329","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H(2)S and Sulfane Sulfur Production","volume":"25","author":"Takano","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kelley, M., Sasaninia, K., Badaoui, A., Glassman, I., Abnousian, A., Rai, N., Tiwari, R.K., and Venketaraman, V. (2025). The effects of cyclic peptide [R4W4] in combination with first-line therapy on the survival of Mycobacterium avium. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1547376"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Briffotaux, J., Xu, Y., Huang, W., Hui, Z., Wang, X., Gicquel, B., and Liu, S. (2022). A Hydrazine-Hydrazone Adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of MmpL3. Molecules, 27.","DOI":"10.3390\/molecules27207130"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ardalani, H., Anam, S., Kromphardt, K.J.K., Staerk, D., and Kongstad, K.T. (2021). Coupling Microplate-Based Antibacterial Assay with Liquid Chromatography for High-Resolution Growth Inhibition Profiling of Crude Extracts: Validation and Proof-of-Concept Study with Staphylococcus aureus. Molecules, 26.","DOI":"10.3390\/molecules26061550"},{"key":"ref_40","unstructured":"(2025, October 16). Antimicrobial Synergy Testing\/Checkerboard Assay. Available online: https:\/\/antiviral.creative-diagnostics.com\/antimicrobial-synergy-testing-checkerboard-assay.html."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Nikolic, I., Vukovic, D., Gavric, D., Cvetanovic, J., Aleksic Sabo, V., Gostimirovic, S., Narancic, J., and Knezevic, P. (2022). An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection. Viruses, 14.","DOI":"10.3390\/v14071542"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:52:31Z","timestamp":1761526351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":41,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110361"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110361","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}